Cite
HARVARD Citation
Wiendl, H. et al. (2022). 116 Serum immunoglobulin levels and infection risk in Phase 3 ofatumumab trials in relapsing multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A137. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wiendl, H. et al. (2022). 116 Serum immunoglobulin levels and infection risk in Phase 3 ofatumumab trials in relapsing multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A137. [Online].